ASP2074

· Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP2074, covering 2025-10-20 to 2025-10-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ASP2074 in Adults With Solid Tumors [Phase 1]